RNA结合蛋白ELAVL1与肿瘤进展的关系研究
CSTR:
作者:
作者单位:

1.南京医科大学第一临床医学院 临床医学系,江苏 南京210029;2.南通大学医学院 临床医学系,江苏 南通 226019;3.南京医科大学附属无锡第二医院 (南通大学附属无锡临床医学院),江苏 无锡 214002

作者简介:

通讯作者:

王浩,E-mail:wangyenn@sina.cn

中图分类号:

R73-3

基金项目:

江苏省无锡市卫健委青年项目(No:Q201824);南通大学临床医学专项(No:2019JZ022)


Review on relationship between RNA-binding protein ELAVL1 and tumor progression
Author:
Affiliation:

1.Department of Clinical Medicine, The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210029, China;2.Department of Clinical Medicine, Medical School of Nantong University, Nantong, Jiangsu 226019, China;3.Nanjing Medical University Affiliated Wuxi Second Hospital (Wuxi Clinical College affiliated to Nantong University), Wuxi, Jiangsu 214002, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    胚胎致死性异常视觉样蛋白1(ELAVL1/HuR)是一种RNA结合蛋白,通过与特定的mRNA结合参与转录后调控,从而影响细胞增殖、凋亡、分化等生物学行为。近年来研究表明,ELAVL1与肿瘤细胞的增殖、血管生成、侵袭、转移及耐药性明显相关。本文就ELAVL1蛋白与肿瘤进展关系展开综述。

    Abstract:

    ELAVL1/HuR is a kind of RNA-binding protein, which belongs to a member of the embryonic lethal abnormal vision (ELAV) family. It selectively stabilizes particular mRNAs and involves in post-transcriptional regulation to mediate a variety of cell behaviors including proliferation, apoptosis, and differentiation. Recent studies show that ELAVL1 is closely related to tumor proliferation, neoangiogenesis, invasion, metastasis, and resistance to cancer therapy. This review gives an overview on the relationship between ELAVL1 and tumor progression.

    参考文献
    相似文献
    引证文献
引用本文

陈禹鑫,殷文婕,蒋壮,徐彤,许之阳,周永平,戴途,王浩. RNA结合蛋白ELAVL1与肿瘤进展的关系研究[J].中国现代医学杂志,2021,(13):65-70

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-12-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-31
  • 出版日期:
文章二维码